' 
![]()
SCIENTIFIC SCORE
Likely Very Effective
Based on 1 Researches
9
USERS' SCORE
Good
Based on 2 Reviews
8.6
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Ubiquinol (Kaneka Ubiquinolâ„¢) (Reduced Form CoQ10)
100 mg
**
Top Medical Research Studies
9
Ubiquinol's impact on blood clotting
Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.
Directly addresses inflammatory markers.
With a focus on antiphospholipid syndrome (APS), we set out to understand how ubiquinol, a reduced form of coenzyme Q10, influences markers related to blood clotting and inflammation. Our study was a well-structured, randomized, placebo-controlled trial involving 36 patients with APS, where we administered 200 mg of ubiquinol daily for one month.
We found that supplementation with ubiquinol notably improved the function of blood vessels and reduced the expression of prothrombotic and inflammatory markers present in monocytes. This suggests that ubiquinol plays a role in reducing the risk of blood clots by enhancing endothelial function and dampening inflammatory responses.
Moreover, our results revealed a significant decrease in harmful molecules and a shift in mitochondrial dynamics, which could further support cardiovascular health. Notably, we also observed positive changes in specific microRNAs and gene expressions linked to atherosclerosis, reinforcing the multifaceted benefits of this treatment.
In summary, ubiquinol has the potential to serve as a beneficial adjunct therapy for managing the thrombotic risks associated with APS, especially given its lack of significant side effects. Our findings indicate that ubiquinol could be a promising option for patients seeking to improve their overall condition related to blood clotting.
We found that supplementation with ubiquinol notably improved the function of blood vessels and reduced the expression of prothrombotic and inflammatory markers present in monocytes. This suggests that ubiquinol plays a role in reducing the risk of blood clots by enhancing endothelial function and dampening inflammatory responses.
Moreover, our results revealed a significant decrease in harmful molecules and a shift in mitochondrial dynamics, which could further support cardiovascular health. Notably, we also observed positive changes in specific microRNAs and gene expressions linked to atherosclerosis, reinforcing the multifaceted benefits of this treatment.
In summary, ubiquinol has the potential to serve as a beneficial adjunct therapy for managing the thrombotic risks associated with APS, especially given its lack of significant side effects. Our findings indicate that ubiquinol could be a promising option for patients seeking to improve their overall condition related to blood clotting.
Read More
Most Useful Reviews
8.3
Improved blood results
I took one tablet daily but felt no effect after a month. After increasing to two tablets, I went for a blood donation and the results the next day showed an improvement in my red and white blood cells, which I struggled to raise previously. I feel less tired and my back was healed in a day. I was often emotionally unstable, but now feel more at ease.
Read More
9.5
No more bleeding
Amazing! When I brushed my teeth, blood came out and I was concerned. I purchased this after hearing that the bleeding from my blood clot would stop within three days of taking ubiquinol. Remarkably, it did stop on the third day. I am surprised.
Read More
Medical Researches
SCIENTIFIC SCORE
Likely Very Effective
Based on 1 Researches
9
9
Ubiquinol's impact on blood clotting
Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.
Directly addresses inflammatory markers.
With a focus on antiphospholipid syndrome (APS), we set out to understand how ubiquinol, a reduced form of coenzyme Q10, influences markers related to blood clotting and inflammation. Our study was a well-structured, randomized, placebo-controlled trial involving 36 patients with APS, where we administered 200 mg of ubiquinol daily for one month.
We found that supplementation with ubiquinol notably improved the function of blood vessels and reduced the expression of prothrombotic and inflammatory markers present in monocytes. This suggests that ubiquinol plays a role in reducing the risk of blood clots by enhancing endothelial function and dampening inflammatory responses.
Moreover, our results revealed a significant decrease in harmful molecules and a shift in mitochondrial dynamics, which could further support cardiovascular health. Notably, we also observed positive changes in specific microRNAs and gene expressions linked to atherosclerosis, reinforcing the multifaceted benefits of this treatment.
In summary, ubiquinol has the potential to serve as a beneficial adjunct therapy for managing the thrombotic risks associated with APS, especially given its lack of significant side effects. Our findings indicate that ubiquinol could be a promising option for patients seeking to improve their overall condition related to blood clotting.
We found that supplementation with ubiquinol notably improved the function of blood vessels and reduced the expression of prothrombotic and inflammatory markers present in monocytes. This suggests that ubiquinol plays a role in reducing the risk of blood clots by enhancing endothelial function and dampening inflammatory responses.
Moreover, our results revealed a significant decrease in harmful molecules and a shift in mitochondrial dynamics, which could further support cardiovascular health. Notably, we also observed positive changes in specific microRNAs and gene expressions linked to atherosclerosis, reinforcing the multifaceted benefits of this treatment.
In summary, ubiquinol has the potential to serve as a beneficial adjunct therapy for managing the thrombotic risks associated with APS, especially given its lack of significant side effects. Our findings indicate that ubiquinol could be a promising option for patients seeking to improve their overall condition related to blood clotting.
Read More
User Reviews
USERS' SCORE
Good
Based on 2 Reviews
8.6
9.5
No more bleeding
Amazing! When I brushed my teeth, blood came out and I was concerned. I purchased this after hearing that the bleeding from my blood clot would stop within three days of taking ubiquinol. Remarkably, it did stop on the third day. I am surprised.
8.3
Improved blood results
I took one tablet daily but felt no effect after a month. After increasing to two tablets, I went for a blood donation and the results the next day showed an improvement in my red and white blood cells, which I struggled to raise previously. I feel less tired and my back was healed in a day. I was often emotionally unstable, but now feel more at ease.
Read More
